Home
›
Aspire Biopharma Holdings, Inc.
› SCHEDULE 13G Feb 26, 2025
Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G filed Feb 26, 2025
Form type
SCHEDULE 13G
Filing date
Feb 26, 2025
Accession number
0001493152-25-008412
Filer
Aspire Biopharma Holdings, Inc.
(CIK 1847345)